Arce; Joan-Carles

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arce; Joan-Carles.The latest application filed is for "methods of treating infertility".

Company Profile

4.10.12

Arce; Joan-Carles - Copenhagen DK
Arce; Joan-Carles - Dragor DK
Arce; Joan-Carles - Parsippany NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating infertility Grant 11,351,228 - Arce , et al. June 7, 2	2022-06-07
Human-derived recombinant FSH for controlled ovarian stimulation Grant 11,291,708 - Arce April 5, 2	2022-04-05
Methods Of Treating Infertility App 20210093697 - Arce; Joan-Carles ; et al.	2021-04-01
Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive Technologies App 20200352962 - Arce; Joan-Carles	2020-11-12
Human-derived Recombinant Fsh For Controlled Ovarian Stimulation App 20200345814 - Arce; Joan-Carles	2020-11-05
Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies Grant 10,688,106 - Arce	2020-06-23
Human-derived recombinant FSH for controlled ovarian stimulation Grant 10,624,953 - Arce	2020-04-21
Methods Of Treating Infertility App 20200093893 - Arce; Joan-Carles ; et al.	2020-03-26
Methods of treating infertility Grant 10,413,592 - Arce , et al. Sept	2019-09-17
Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies Grant 10,183,029 - Arce Ja	2019-01-22
Composition for Controlled Ovarian Stimulation App 20180028620 - Arce; Joan-Carles	2018-02-01
Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive Technologies App 20170348325 - Arce; Joan-Carles	2017-12-07
Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive Technologies App 20170189415 - Arce; Joan-Carles	2017-07-06
FSH composition and methods for controlled ovarian stimulation Grant 9,694,052 - Arce July 4, 2	2017-07-04
Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies Grant 9,579,305 - Arce February 28, 2	2017-02-28
Methods Of Treating Infertility App 20160250296 - Arce; Joan-Carles ; et al.	2016-09-01
Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive Technologies App 20160175283 - Arce; Joan-Carles	2016-06-23
Composition for Controlled Ovarian Stimulation App 20140329748 - Arce; Joan-Carles	2014-11-06
Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist Grant 8,334,298 - Pellicer-Martinez , et al. December 18, 2	2012-12-18
Treatment or Prevention of Ovarian Hyperstimulation Syndrome (Ohss) Using a Dopamine Agonist App 20080293693 - Pellicer-Martinez; Antonio ; et al.	2008-11-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.